>Manipulation of the coronavirus genome using targeted RNA recombination with interspecies chimeric coronaviruses
The Lieber group has a large program focused on a conceptually novel approach for integrating electronics within the brain and other areas of the nervous system
a broad range of studies focused on development of syringe-injectable mesh electronics
We are also using syringe-injectable mesh electronics for studies in a variety of other CNS/PNS regions, including recording and stimulation of the retina, spinal cord, neuromuscular junctions, which are extremely difficult, if possible, to access using conventional rigid electronics.
>Nanoelectronic probes & cyborg cells. We are pursuing a broad range of studies focused on development of novel nanoelectronic devices for electrical recording and stimulation from cells and tissue in two and three dimensions. A general theme in this work is to exploit unique properties and size-scaling of active nanoelectronic devices for high spatial/temporal resolution studies of individual cells and subcellular structures.
pursuing the development of novel biomaterials that seamlessly integrate arrays of nanoelectronic devices with synthetic tissues. This highly interdisciplinary work involves implementation of our new paradigm for 3D nanodevice arrays
http://cml.harvard.edu/research/nano-bioelectronics
[Charles] Lieber has been a pioneer in nanoscience and nanotechnology where he has originated new paradigms that have defined the rational growth, characterization,
https://www.sciencemag.org/news/2020/02/why-did-chinese-university-hire-charles-lieber-do-battery-research
https://www.nature.com/articles/d41586-020-00291-2